AYURVEDIC UTTARAVASTI PROCEDURE IN THE MANAGEMENT OF INFERTILITY USING KIDRAKUMARI TAILAM: AN EVIDENCE BASED CLINICAL STUDY

Dr. M. Ramavani* and Dr. Morusupalli Dilip

ABSTRACT

Infertility is defined as a person's biological incapacity to contribute to conception. The goal of this study was to determine the role of uttaravasti in tubal obstruction, PCOD, and premature ovarian failure, as well as to establish it as a safer and more cost-effective Ayurvedic therapeutic option. Unilateral or bilateral tubal obstruction PCOD and premature ovarian failure identified in hysterosalpingography (HSG) Ultrasonography were used to select patients and assess results. The study included 62 patients in the reproductive age range who had 62.50 percent PCOD and 37.50 percent bilateral tubal obstruction. The treatment was completed by 52 patients. Patients with active infections or chronic illnesses were excluded from the study. The Vata Kapha Shamaka and Lekhana characteristics of Kidra Kumari Taila were chosen. The dose of uttaravasti was 3- 5 ml per cycle, with two cycles in between (three days of uttaravasthi in each cycle). Following the conclusion of menstruation, uttaravasti was given to the patients who had been tested through haematological, urinary, and serological (HIV, VDRL, HBsAg) studies. In 80 percent of the patients, the tubal obstruction and PCOD were eliminated, and 40 percent of the patients conceived within the two-month follow-up period. According to the findings, uttaravasti with kidra kumari tailam is a highly effective therapy method for tubal obstruction, PCOD, and premature ovarian failure with no known side effects.

Keywords: Infertility, Kidra Kumari Taila, PCOD, Ayurveda, Uttaravasti, Uterus.